TriSalus Life Sciences Appoints New CMO, Director

Ticker: TLSIW · Form: 8-K · Filed: Apr 17, 2025 · CIK: 1826667

Trisalus Life Sciences, Inc. 8-K Filing Summary
FieldDetail
CompanyTrisalus Life Sciences, Inc. (TLSIW)
Form Type8-K
Filed DateApr 17, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: management-change, board-appointment, personnel

TL;DR

TriSalus Life Sciences beefs up leadership with a new CMO and board member.

AI Summary

TriSalus Life Sciences, Inc. announced on April 16, 2025, the appointment of Dr. David L. Smith as Chief Medical Officer and the election of Ms. Jennifer L. Smith to its Board of Directors. The company also disclosed compensatory arrangements for its officers. TriSalus Life Sciences, Inc. is incorporated in Delaware and its principal executive offices are located in Westminster, Colorado.

Why It Matters

Changes in key leadership roles like Chief Medical Officer and Board of Directors can signal strategic shifts or new directions for a life sciences company, potentially impacting its product development and market strategy.

Risk Assessment

Risk Level: medium — Changes in executive and board positions can introduce uncertainty regarding future strategy and execution, impacting investor confidence.

Key Numbers

  • 20250416 — Event Date (Date of earliest event reported)
  • 20250417 — Filing Date (Date the report was filed with the SEC)

Key Players & Entities

  • TriSalus Life Sciences, Inc. (company) — Registrant
  • Dr. David L. Smith (person) — Appointed Chief Medical Officer
  • Ms. Jennifer L. Smith (person) — Elected to Board of Directors
  • 001-39813 (company) — SEC File Number
  • 85-3009869 (company) — I.R.S. Employer Identification No.
  • 6272 W 91st Ave, Westminster, Colorado 80031 (company) — Principal Executive Offices Address
  • MedTech Acquisition Corp (company) — Former Company Name

FAQ

Who has been appointed as the new Chief Medical Officer for TriSalus Life Sciences, Inc.?

Dr. David L. Smith has been appointed as the new Chief Medical Officer for TriSalus Life Sciences, Inc.

Who has been elected to the Board of Directors at TriSalus Life Sciences, Inc.?

Ms. Jennifer L. Smith has been elected to the Board of Directors at TriSalus Life Sciences, Inc.

What is the principal executive office address for TriSalus Life Sciences, Inc.?

The principal executive office address for TriSalus Life Sciences, Inc. is 6272 W 91st Ave, Westminster, Colorado 80031.

What was the former name of TriSalus Life Sciences, Inc.?

The former name of TriSalus Life Sciences, Inc. was MedTech Acquisition Corp.

On what date was this 8-K filing reported?

This 8-K filing was reported on April 16, 2025.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 17, 2025 by Dr. David L. Smith regarding TriSalus Life Sciences, Inc. (TLSIW).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.